Immunology

Study identifies two different regulatory T cell populations

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children's Hospital of Philadelphia (CHOP). ...

Oncology & Cancer

Study uncovers new treatment approaches for liver cancer patients

Experts from Cedars-Sinai Cancer have analyzed patient samples, along with studies conducted in animal models, to identify a novel immune checkpoint pathway to treat hepatocellular carcinoma, the most common form of liver ...

Cardiology

AI predicts if—and when—someone will have cardiac arrest

A new artificial intelligence-based approach can predict, significantly more accurately than a doctor, if and when a patient could die of cardiac arrest. The technology, built on raw images of patient's diseased hearts and ...

Cardiology

Heart study: Low- and regular-dose aspirin safe, effective

An unusual study that had thousands of heart disease patients enroll themselves and track their health online as they took low- or regular-strength aspirin concludes that both doses seem equally safe and effective for preventing ...

Diseases, Conditions, Syndromes

COVID-19 cytokine storms may prevent a durable immune response

Shiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical School (HMS), recently published a paper in Cell showing that high levels of some cytokines seen in COVID-19 ...

Immunology

Finding what fuels the 'runaway train' of autoimmune disease

A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.

page 2 from 40